|
|
Modulatory Neurotransmitter Systems and Their Role in Brain Diseases The modulatory neurotransmitter systems include several aminergic and peptidergic neuron systems and their long projections in the vertebrate brain. These transmitters use a large number of G protein-coupled receptors, which share signal transduction systems in cells. In addition to regulating key physiological functions, many of these systems are involved in important human neurodegenerative diseases. Our research focuses on identification and functional roles of new modulatory systems, and their functional roles in brain diseases. A particular target is the histaminergic system, which has important interactions with other aminergic (e.g. dopaminergic) and peptidergic systems in regulation of, for instance, e.g. sleep, diurnal rhythms, feeding, and addiction. Using new algorithms, novel receptors were identified in databases. They were cloned in several species and expression analyses suggest that they regulate important functions. New methods were developed to use zebrafish in combined studies of complex neuronal systems. Confocal and two-photon imaging systems allow three-dimensional imaging of whole neurotransmitter systems in the zebrafish brain at a time when the fish already display complex behaviors. Quantitative behavioral analysis systems were developed to simultaneously analyze the behaviour of up to 100 fish. Identification and cloning of fish orthologs of important human disease genes with poorly known functions and translation inhibition and identification of mutant zebrafish are followed by phenotypic analysis using the new imaging and behavioural methods. The methods created in the project also allow use of zebrafish in the development of new drugs for central nervous system disorders, including those related to motor functions, anxiety-related behaviour, and memory. Selected publications Peitsaro, N., Sundvik, M., Anichtchik, O.V., Kaslin, J., and Panula, P. (2007). Identification of zebrafish histamine H1, H2 and H3 receptors and effects of histaminergic ligands on behavior. Biochem. Pharmacol. 73:1205-14. Bongers, G., Sallmen, T., Passani, M.B., Mariottini, C., Wendelin, D., Lozada, A., Marle, A., Navis, M., Blandina, P., Bakker, R.A., Panula, P., and Leurs, R. (2007). The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor. J. Neurochem. 103: 248-258. |